跳至主要内容
临床试验/NL-OMON35325
NL-OMON35325
已完成
不适用

Dutch randomized trial comparing standard catheter-directed thrombolysis versus ultrasound-accelerated thrombolysis for thrombo-embolic infra-inguinal disease. - DUET study

Sint Antonius Ziekenhuis0 个研究点目标入组 60 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
thrombo-embolic infra-inguinal arterial occlusion / thrombosed leg artery
发起方
Sint Antonius Ziekenhuis
入组人数
60
状态
已完成
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
去年
研究类型
Interventional

研究者

入排标准

入选标准

  • 1\. Patients with recently (between 1 and 7 weeks) thrombosed femoro\-popliteal or femoro\-crural native arteries with ischemic complaints.
  • 2\. Patients with recently (between 1 and 7 weeks) thrombosed femoro\-popliteal or femoro\-crural venous or prosthetic bypass grafts with ischemic complaints.
  • 3\. Limb ischemia class I and IIa according to the Rutherford classification for acute ischemia.
  • 4\. Patients \>18 years and \< 85 years old.
  • 5\. Patients understand the nature of the procedure and provide written informed consent, prior to enrolment in the study

排除标准

  • 1\. Patients with isolated common femoral artery thrombosis including the origin of the superficial femoral artery and profunda femoral artery.
  • 2\. Patients with localized (\<5 cm) emboli / occlusions in the native femoropopliteal arteries
  • 3\. Patients with clinical complaints of lower limb ischemia due to thrombosis of the native femoro\-crural arteries or femoro\-popliteal and femoro\-crural bypass grafts \<1 week and \>7 weeks.
  • 4\. Patients with acute lower limb ischemia class IIb and III according to the Rutherford classification (see below).
  • 5\. Patients for whom antiplatelet therapy, anticoagulants or thrombolytic drugs are contraindicated
  • 6\. Recent (\< 6 weeks) ischemic stroke or cerebral bleeding
  • 7\. Patients with recent (\<6 weeks) surgery
  • 8\. Severe hypertension (diastolic blood pressure \>110 mmHg, systolic blood pressure \>200 mmHg)
  • 9\. Current malignancy
  • 10\. Patients with a history of prior life\-threatening contrast medium reaction

结局指标

主要结局

未指定

相似试验